2022
DOI: 10.3892/mmr.2022.12767
|View full text |Cite
|
Sign up to set email alerts
|

Circ_0006174 promotes the malignancy of colorectal cancer cell via the miR‑1205/CCBE1/Wnt pathway

Abstract: Circular RNAs (circRNAs) are novel RNA transcripts that participate in cancer development. Nonetheless, in colorectal cancer (CRC), the information ~circRNA expression and function is largely unknown. The present study aimed to investigate the expression, function and underlying mechanism of circ_0006174 in CRC. Reverse transcription-quantitative PCR analysis was performed to detect circ_0006174, miR-1205 and calcium-binding epidermal growth factor domain-containing protein 1 (CCBE1) expression levels in CRC t… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 7 publications
(1 citation statement)
references
References 28 publications
0
1
0
Order By: Relevance
“…Currently, it is believed that family heredity, dietary habits, lifestyle and environment may be the predisposing factors of CRC, but the specific etiology has not been clarified (Zhou et al 2022b ). Despite the high cure rate of CRC patients treated in the early stage, the 5-year survival rate of most patients with advanced or metastatic disease is only 10% (Zhao et al 2022 ). Based on this, the identification of patients at risk of recurrence by sensitive biomarkers has key practical implications for the treatment of CRC.…”
Section: Introductionmentioning
confidence: 99%
“…Currently, it is believed that family heredity, dietary habits, lifestyle and environment may be the predisposing factors of CRC, but the specific etiology has not been clarified (Zhou et al 2022b ). Despite the high cure rate of CRC patients treated in the early stage, the 5-year survival rate of most patients with advanced or metastatic disease is only 10% (Zhao et al 2022 ). Based on this, the identification of patients at risk of recurrence by sensitive biomarkers has key practical implications for the treatment of CRC.…”
Section: Introductionmentioning
confidence: 99%